Biotech and Healthcare Stock Market News - Stocks to Watch from BioMedReports.com | Page 9

Subscriber Only Content

May be wise to wait before jumping in
This note is being posted for premium subscribers only. Read More
Posted 05/21/2012
Healthcare Insider Buys at Mid-May
This information is being posted for premium subscribers only: Read More
Posted 05/16/2012
Another Biotech Buyout Target?
This information is being posted for premium subscribers first. Read More
Posted 05/11/2012

Breaking News

IVAX Diagnostics, Inc. Reports First Quarter 2012 Financial Results
In first quarter, continues to cut operating loss to almost break-even and increase re... Read More
Posted 05/21/2012
Verastem to Host NASDAQ Opening in its Cambridge Laboratory May 22, 2012
Verastem, Inc.Investor contact:Brian Sullivan, 617-252-9314bsullivan@verastem.comorMed... Read More
Posted 05/21/2012
Covidien Appoints Gregory S. Andrulonis Vice President and Treasurer
Read More
Posted 05/21/2012
Virginia Bio Names Jeffrey M. Gallagher Interim Executive Director
Virginia Biotechnology AssociationSherri Halloran, 804-643-6360 Read More
Posted 05/21/2012
Pearl Therapeutics Receives TiE50 Award from Global Entrepreneurship Network
REDWOOD CITY, Calif., May 21, 2012/PRNewswire/ -- Pearl Therapeutics Inc. has b... Read More
Posted 05/21/2012
Organovo Appoints Dr. Eric Michael David As Chief Strategy Officer
SAN DIEGO, May 21, 2012/PRNewswire/ -- Organovo Holdings, Inc.(OTCQB: ONVO) ("... Read More
Posted 05/21/2012
Keryx Biopharmaceuticals Announces Upcoming Poster Presentation of Zerenex™ (ferric citrate) at the 49th ERA-EDTA Congress
Read More
Posted 05/21/2012
Citizen Scientists Seek Microbes at the Edge of Space
SAN MATEO, Calif., May 21, 2012/PRNewswire/ -- A NASA-inspired competition ... Read More
Posted 05/21/2012
PRA Expands Operations in Europe
RALEIGH, N.C., May 21, 2012/PRNewswire/ -- PRA, a leading Clinical Researc... Read More
Posted 05/21/2012
Cerecor Announces Initiation of CLIN01-002-A
BALTIMORE, May 21, 2012/PRNewswire/ -- Cerecor Inc., a biopharmaceutical compa... Read More
Posted 05/21/2012
Genesis Biopharma Issues Letter To Shareholders
LOS ANGELES, May 21, 2012/PRNewswire/ -- Genesis Biopharma, Inc. (OTC/BB: GNBP),... Read More
Posted 05/21/2012
Neuralstem CEO to Present at the World Stem Cells and Regenerative Medicine Congress in London
ROCKVILLE, Md., May 21, 2012/PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) an... Read More
Posted 05/21/2012
Aushon steht vor Einführung einer neuen Plattform für Multiplex-Immunoassays
- Leistungsfähigkeit auf ELISA-Niveau mit Möglichkeit zur Parallelanalyse von ... Read More
Posted 05/21/2012
Lancement d'une nouvelle plate-forme d'immuno-essai par Aushon
- Niveaux de performance comparables à ELISA avec la puissance de l'analyse par... Read More
Posted 05/21/2012

RSS Subscription

Abbott hepatitis drug 93% effective in small study; GTx Submits Clinical Hold Complete Response Letter To FDA

Below is a look at some of the headlines for companies that made news in the healthcare sector on April 4, 2012.
Read more...

Using transgenic technology for various applications in humans define Pharming Group NV

Trading on the Euronext, Pharming Group NV (NYSE Euronext: PHARM) produces, purifies and formulates recombinant human proteins using its transgenic technology platform for therapeutic indications in Hereditary Angioedema, Transplant Rejection, Blood Coagulation Disorders and Ischemic Reperfusion Injury.
Read more...

Onyx Pharma's Phase 3 Trial of Regorafenib Meets Primary Endpoint; Amylin Completes Biologics License Application for Metreleptin

Below is a look at some of the headlines for companies that made news in the healthcare sector on April 3, 2012.
Read more...

Upcoming Phase IIa trials results make Achillion worth watching

Achillion Pharmaceuticals (ACHN) is a development-stage pharmaceutical company developing treatments that combat the heptatitis C virus, which is estimated by the company’s website to affect over 170 million worldwide.
Read more...

FDA Approves Levemir® for Women with Diabetes; Keryx Announces Top-Line Data from the Perifosine

Below is a look at some of the headlines for companies that made news in the healthcare sector on April 2, 2012.
Read more...

Co-founder of biotech powerhouse, ImClone Systems, sees perhaps even greater potential at Neptune subsidiary

Two of our favorite biotech companies are tied at the hip, but one of them does not yet trade in the U.S. With a key upcoming catalyst that could see big pharma lining up with partnership offers, is there a way for American traders and investors to get skin in the game?
Read more...